| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/20/2011 | CN102127524A Method for proliferating avian influenza viruses in bioreactor with cell carrier |
| 07/20/2011 | CN102127168A Recombinant fusion protein of triggering receptor-1 expressed on myeloid cells (TREM-1) and application thereof |
| 07/20/2011 | CN102127167A Whole human TNF alpha (tumor necrosis factor alpha) monoclonal antibody and preparation and application thereof |
| 07/20/2011 | CN102127162A Alzheimer's disease dendritic cell (DC) vaccine prepared by stimulation by mutant Abeta polypeptide |
| 07/20/2011 | CN102127150A Nestin portion polypeptide and application thereof |
| 07/20/2011 | CN102127147A Mimotope of epidermal growth factor receptor (EGFR) and use thereof |
| 07/20/2011 | CN102125687A Production method for bivalent inactivated vaccine for infectious serositis of ducks |
| 07/20/2011 | CN101245106B Anti-VRGF acceptor monoclone antibody, preparation method and application thereof |
| 07/20/2011 | CN101215576B Rabbit viral haemorrhagic virus capsid protein gene recombination baculovirus and vaccine |
| 07/20/2011 | CN101113177B Method for separating and purifying anti-hepatitis B immune globulin from plasma or plasma component |
| 07/19/2011 | US7982025 Fusion proteins of Mycobacterium tuberculosis |
| 07/19/2011 | US7982024 Antibodies to insulin-like growth factor I receptor |
| 07/19/2011 | US7982017 Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same |
| 07/19/2011 | US7982015 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/19/2011 | US7982014 FGFR3-IIIc fusion proteins |
| 07/19/2011 | US7982013 Frizzled-binding agents and uses thereof |
| 07/19/2011 | US7982012 Compositions and methods for the therapy and diagnosis of cytomegalovirus |
| 07/19/2011 | US7982011 Mutated anti-cd22 antibodies and immunoconjugates |
| 07/19/2011 | US7982004 Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer |
| 07/19/2011 | US7981873 Use within transplantation surgery |
| 07/19/2011 | US7981865 Antigenic fragments of human factor VIII polypeptides |
| 07/19/2011 | US7981673 Process for the maturation of dendritic cells and a vaccine |
| 07/19/2011 | US7981672 Monoclonal antibody and use thereof |
| 07/19/2011 | US7981671 Use of triplex structure DNA in transferring nucleotide sequences |
| 07/19/2011 | US7981656 Pseudotyped retrovirus with modified ebola glycoprotein |
| 07/19/2011 | US7981631 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment and monitoring of periodontal diseases |
| 07/19/2011 | US7981614 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 07/19/2011 | US7981601 Method of preparing polyepitope chimeric gene vaccine |
| 07/19/2011 | US7981434 Surface exposed immunoglobulin D-binding protein from Moraxella catarrhalis |
| 07/19/2011 | US7981433 Targeted delivery of botulinum toxin to the sphenopalatine ganglion |
| 07/19/2011 | US7981431 Consensus dengue virus envelope protein domain III polypeptides (cED III) and their methods of use |
| 07/19/2011 | US7981430 Multi-clade chimeric immunogens derived from highly conserved regions of the human immunodeficiency virus type 1 (HIV-1) consensus proteome |
| 07/19/2011 | US7981429 Influenza hemagglutinin and neuraminidase variants |
| 07/19/2011 | US7981428 Flu vaccines and methods of use thereof |
| 07/19/2011 | US7981427 has a low level of homology to the enteric canine coronavirus, but which has a high level of homology to all bovine coronavirus strains (eg Quebec and LY138) and human coronavirus strain OC43 |
| 07/19/2011 | US7981425 Thrombopoietic compounds |
| 07/19/2011 | US7981424 RAGE fusion proteins, formulations, and methods of use thereof |
| 07/19/2011 | US7981423 Rage fusion proteins |
| 07/19/2011 | US7981422 Antibodies against West Nile Virus and therapeutic and prophylactic uses thereof |
| 07/19/2011 | US7981421 Combinations of antibodies selective for DR5 and other therapeutic agents |
| 07/19/2011 | US7981420 Therapeutic use of antibodies directed against repulsive guidance molecule (RGM) |
| 07/19/2011 | US7981419 Method for treating hypophosphatemic bone diseases using FGF-23 antibody |
| 07/19/2011 | US7981418 Predicting response to a HER inhibitor |
| 07/19/2011 | US7981417 Blood-brain barrier targeting anti-bodies |
| 07/19/2011 | US7981416 Humanized immunomodulatory monoclonal antibodies for the treatment of immunodeficiency |
| 07/19/2011 | US7981415 bind and neutralize Plasminogen Activator Inhibitor-1 (PAI-1) by converting PAI-1 to its latent form or increasing proteolytic cleavage; treating a fibrotic condition; inhibits accumulation of extracellular matrix (ECM); liver fibrosis |
| 07/19/2011 | US7981414 Anti-inflammatory dAb |
| 07/19/2011 | US7981413 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 07/19/2011 | US7981398 PEGylation by the dock and lock (DNL) technique |
| 07/19/2011 | CA2477232C Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders |
| 07/19/2011 | CA2440890C Tumor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors |
| 07/19/2011 | CA2434314C Method to enhance the immunogenicity of an antigen |
| 07/19/2011 | CA2401906C Kcnb: a novel potassium channel protein |
| 07/19/2011 | CA2397354C O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
| 07/19/2011 | CA2281952C Compounds for immunotherapy of prostate cancer and methods for their use |
| 07/19/2011 | CA2185656C Protein tyrosine kinase agonist antibodies |
| 07/18/2011 | CA2785774A1 Tumor tissue based biomarkers for bevacizumab combination therapies |
| 07/14/2011 | WO2011085367A2 Non-replicating microorganisms as post-biotics |
| 07/14/2011 | WO2011085354A1 Enhanced cytotoxicity of anti-cd74 and anti-hla-dr antibodies with interferon-gamma |
| 07/14/2011 | WO2011085289A1 Production of a monoclonal antibody therapeutic against west nile virus in plants |
| 07/14/2011 | WO2011085231A2 Synthetic virus-like particles conjugated to human papillomavirus capsid peptides for use as vaccines |
| 07/14/2011 | WO2011085178A1 Monomeric bi-specific fusion protein |
| 07/14/2011 | WO2011085103A2 Plasma kallikrein binding proteins |
| 07/14/2011 | WO2011085071A2 Attenuated francisella mutants and methods of use |
| 07/14/2011 | WO2011084967A2 Methods and compositions for providing protective immunity in the elderly |
| 07/14/2011 | WO2011084882A2 Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria |
| 07/14/2011 | WO2011084783A2 Novel pneumovirus compositions and methods for using the same |
| 07/14/2011 | WO2011084750A1 Antibody formulation |
| 07/14/2011 | WO2011084748A2 Photo-inactivated viruses and systems and methods of using the same |
| 07/14/2011 | WO2011084726A1 BIS [4-AMINO-2-(ETHOXYMETHYL)-1-(2-HYDROXY-2-METHYLPROPYL)-1H-IMIDAZO[4,5-c]QUINOLIN-5-IUM] 4-[(3-CARBOXYLATO-2-HYDROXYNAPHTHALEN-1-YL)METHYL]-3-HYDROXYNAPHTHALENE-2-CARBOXYLATE COMPOSITIONS AND METHODS |
| 07/14/2011 | WO2011084725A1 4-AMINO-2-(ETHOXYMETHYL)-1-(2-HYDROXY-2-METHYLPROPYL)-1H-IMIDAZO[4,5-c]QUINOLIN-5-IUM 1-HYDROXYNAPHTHALENE-2-CARBOXYLATE COMPOSITIONS AND METHODS |
| 07/14/2011 | WO2011084714A2 STABILIZED ANTI-TNF-ALPHA scFv MOLECULES OR ANTI-TWEAK scFv MOLECULES AND USES THEREOF |
| 07/14/2011 | WO2011084605A1 Anti-prostate cancer antibodies and methods of detection and treatment of prostate cancer using the same |
| 07/14/2011 | WO2011084604A2 Flavivirus species-specific peptide tags for vaccine and diagnostic use |
| 07/14/2011 | WO2011084507A1 Treatment of nasal and sinus disorders |
| 07/14/2011 | WO2011083881A1 Vaccine for treatment of tautopathy |
| 07/14/2011 | WO2011083830A1 Novel anticancer agent and method for screening same |
| 07/14/2011 | WO2011083637A1 Therapeutic agent for hepatic disorder |
| 07/14/2011 | WO2011083493A1 Human chorionic gonadotropin (hcg) based vaccine for prevention and treatment of cancer |
| 07/14/2011 | WO2011083477A1 Immuno-tolerance formulations |
| 07/14/2011 | WO2011083296A1 T cell clonotypes |
| 07/14/2011 | WO2011083147A1 Wave1 inhibition in the medical intervention of inflammatory diseases and/or infections caused by a pathogen |
| 07/14/2011 | WO2011083091A2 Methods for treating pancreatic cancer |
| 07/14/2011 | WO2011083090A2 Methods for treating breast cancer |
| 07/14/2011 | WO2011061700A3 Ifnϒ inhibitors in the treatment of motoneuron diseases |
| 07/14/2011 | WO2011050384A3 Pharmaceutical composition for the treatment and prevention of a rhinovirus infection |
| 07/14/2011 | WO2011035158A3 Nasal, wound and skin formulations and methods for control of antibiotic-resistant staphylococci and other gram-positive bacteria |
| 07/14/2011 | WO2011028064A3 Novel bacteriophage and antibacterial composition comprising the same |
| 07/14/2011 | WO2011028061A3 Novel bacteriophage and antibacterial composition comprising the same |
| 07/14/2011 | WO2011028059A3 Novel bacteriophage and antibacterial composition comprising the same |
| 07/14/2011 | WO2011028057A3 Novel bacteriophage and antibacterial composition comprising the same |
| 07/14/2011 | WO2011025883A3 Natural igm antibodies |
| 07/14/2011 | WO2010144140A4 Egfr and par2 regulation of intestinal permeability |
| 07/14/2011 | WO2010113117A3 Preparation of isolated agonist anti-edar monoclonal antibodies |
| 07/14/2011 | WO2010070453A8 Meningococcal vaccines including hemoglobin receptor |
| 07/14/2011 | WO2010042644A8 Methods for inducing a sustained immune response againts a b-cell idiotype using autologous anti-idiotypic vaccines |
| 07/14/2011 | US20110172406 Molecular structure of rhd negative |
| 07/14/2011 | US20110172397 Anti-psgl-1 antibodies |
| 07/14/2011 | US20110172114 Compositions and methods for the treatment of immune related diseases |
| 07/14/2011 | US20110171316 Expression and assembly of human group c rotavirus-like particles and uses thereof |